Mr. ZHANG Weitong has been responsible for the overall operation and management of our Group since December 2018. He acted as our President from December 2018 to June 2024, and has been our Director since January 2019, and the Chairman of the Board since July 2022. Mr. Zhang has played a core role in, among others, achieving growth of revenue and profit, and enhancing profitability and brand influence of our Group.

Mr. Zhang joined our Group in April 2000 and successively served as a regional sales manager, a department manager, an assistant to the general manager, a vice general manager and a senior vice general manager from April 2000 to February 2018. Mr. Zhang was successively responsible for overseeing our Group's branches in southern China and eastern China. During the term when he was serving as the senior vice general manger from January2017 to February 2018, he was responsible for overseeing our Group’s marketing department, product R&D department, bidding office, corporate affairs department, and our Group's various sales regions, and responsible for assisting the general manager in, among others, sales management and operation coordination.

Mr. Zhang has approximately 30 years of experience in beverage industry. Before joining our Group, Mr. Zhang has served as an assistant to the general manager in Weiyuan Beverage & Food (Shenzhen) Co., Ltd. from October 1994 to April 2000. He served as the standing vice general manager (presiding over the work) and the general manager of China Resources Ng Fung Limited from February 2018 to December 2018.

Mr. Zhang obtained his EMBA degree from Sun Yat-sen University in Guangdong Province, the PRC in June 2012.

Mr. LI Shuqing has been our President since June 2024, and has been our Director since August 2024.

Mr. Li served as a salesman of Shijiazhuang Branch of China Resources Head Office, whose headquarters is now known as China Resources Company Limited, from August 1994 to February 1997. He served as a staff member of the human resources department of China Resources Company Limited from February 1997 to May 2000. Mr. Li then served in China Resources Ng Fung Limited (formerly known as Ng Fung Hong Limited), consecutively as a director of the human resources and administration department, an assistant manager, a vice manager, a manager and a senior manager from May 2000 to November 2010, and as an assistant general manager from November 2010 to September 2011. He then served in CR Holdings from September 2011 to June 2022 and held several positions including an assistant general manager of the office of the board of directors, an assistant director of the general office and a vice director of the general office. Mr. Li served as a vice general manager of China Resources Pharmaceutical Commercial Group Co., Ltd. from June 2022 to November 2023. He then served as a vice general manager of China Resources Ng Fung Limited from November 2023 to June 2024.

Mr. Li obtained his bachelor's degree majoring in international trade from University of International Business and Economicsin Beijing, the PRC in June 1994.

Ms. WU Xia was appointed as our Director and Chief Financial Officer since April 2024.

Prior to joining our Group, Ms. Wu worked in Jiangzhong Pharmaceutical Co., Ltd. (a company listed on the Shanghai Stock Exchange (stock code: 600750)) from March 2005 to June 2020, and successively held several positions including the financial manager, the chief financial officer, the secretary to the board and the vice general manager, including serving as the chief financial officer from April 2009 to May 2015, and the secretary to the board from August 2009 to May 2012. From June 2020 to April 2024, Ms. Wu served as the deputy general manager in China Resources Jiangzhong Pharmaceutical Group Co., Ltd..

Ms. Wu obtained her master's degree majoring in accounting in Jiangxi University of Finance and Economics in Jiangxi, the PRC in June 2010. She was qualified as a senior accountant of the PRC in December 2011.

Mr. LIN Guolong was appointed as a non-executive Director in April 2024.

Mr. Lin served as the vice president and the chief financial officer in China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (a company listed on the Shenzhen Stock Exchange (stock code: 000999)) from August 2011 to July 2018. He worked in the finance department of CR Holdings from July 2018 to August 2021, with his last position as a deputy general manager. Mr. Lin has been a designated external director of the business unit of CR Group since August 2021 including serving as an external director of China Resources Capital Holdings Company Limited since November 2021, a non-executive Director of China Resources Pharmaceutical Group Limited (a company listed on the Stock Exchange (stock code: 3320)) from September 2021 to December 2023, and a director of China Resources Double-Crane Pharmaceutical Co., Ltd. (a company listed on the Shanghai Stock Exchange (stock code: 600062)) since October 2023.

Mr. Lin obtained his master's degree majoring in business and administration from University of South Australia in the Australia in March 2007.

Mr. SUN Yongqiang was appointed as a non-executive Director in April 2024.

Mr. Sun successively worked in Beijing Dyestuffs Plant Co., Ltd. (formerly known as Beijing Dyestuffs Plant) and Beijing Haidong Air Purification Technology Development Company from August 1992 to September 1998. Mr. Sun joined the CR Group in November 1998, and served in China Resources Land (Beijing) Co., Ltd. (formerly known as Beijing Huayuan Real Estate Co., Ltd.) from November 1998 to November 2006, with his last position as a department manager of the research and development department. He served as a vice general manager in China Resources Land (Hunan) Co., Ltd. from November 2006 to July 2009, and as a general manager from July 2009 to January 2011. He has served in CR Land from January 2011 to September 2023, with his last position as a vice president. He concurrently served as a vice general manager of Hainan Development Holdings Co., Ltd. from October 2020 to October 2022. Mr. Sun has served as a non-executive director of China Resources Pharmaceutical Group Limited (a company listed on the Stock Exchange (stock code: 3320)) since December 2023.

Mr. Sun obtained his bachelor's degree in engineering majoring in thermal engineering from Dalian University of Technology in Liaoning Province, the PRC in July 1992. He was qualified as a senior economist in December 2003 and an engineer in September 1998 in the PRC.

Mr. XIAO Ning was appointed as a non-executive Director in April 2024.

Mr. Xiao served as the deputy manager of the legal department of China Resources Company Limited from August 1996 to September 2000. He started to work in China Resources Petrochemical (Group) Co., Ltd. from September 2000 and held several positions including an assistant manager of investment development department from September 2001 to September 2002, a manager of investment development department from October 2002 to February 2004, and a senior manager of investment development department from February 2004 to June 2007. Mr. Xiao then held several positions in CR Chemical (formerly known as China Resources Chemical Holdings Co., Ltd. and its subsidiaries, including the assistant to general manager and a legal director. Mr. Xiao then served as the deputy general manager of CR Chemical from April 2020 to August 2022. Mr. Xiao has served as a director of China Resources Microelectronics Limited (a company listed on the Shanghai Stock Exchange (stock code: 688396)) since November 2022.

Mr. Xiao obtained his master's degree majoring in business administration from Xiamen University in Fujian, the PRC in June 2013.

Ms. CAO Yue has been our Director since August 2023.

Ms. Cao served in KPMG Huazhen LLP as an audit manager from August 2005 to August 2013. After that, she has served in Plateau Consumer Fund, L.P..

Ms. Cao obtained her master's degree majoring in quantitative economics in June 2005 from Renmin University of China in Beijing, the PRC. Ms. Cao is a qualified member of the Chinese Institute of Certified Public Accountants. She was qualified as a Certified Internal Auditor of the PRC in November 2009.

Dr. ZHAO Dian has been our Director since August 2022.

Dr. Zhao served as a lawyer in Zhonglun Law Firm from December 2010 to June 2016. He worked as a vice president in the equity investment platform of Zhong Ou Asset Management Company Limited from June 2016 to August 2020. After that, he has served in Plateau Consumer Fund, L.P..

Dr. Zhao obtained his doctoral degree majoring in civil and commercial law from the Graduate School of Chinese Academy of Social Sciences in Beijing, the PRC in June 2016. Dr. Zhao obtained the PRC legal professional qualification in March 2012.

Dr. CHOW Wing Kin Anthony was appointed as our independent non-executive Director in October 2024.

Dr. Chow is a solicitor and admitted to practice in Hong Kong and England & Wales and a China-Appointed Attesting Officer .

Dr. Chow established the law firm Anthony W.K, Chow & Co. in September 1982 which has since become Guantao and Chow Solicitors and Notaries of which he is the Senior Consultant. Dr. Chow served as an independent non-executive director of MTR Corporation Limited (a company listed on the Stock Exchange (stock code: 0066)) from May 2016 to May 2022, and an independent non-executive director of S.F. Holding Co., Ltd. (a company listed on the Shenzhen Stock Exchange (stock code: 002352)) from December 2016 to December 2022. Dr. Chow currently serves as director of a number of listed companies, including: (i) a non-executive director of the Kingmaker Footwear Holdings Limited (a company listed on the Stock Exchange (stock code: 1170)) since June 1994, (ii) an independent non-executive director of Ping An Healthcare and Technology Company Limited (a company listed on the Stock Exchange (stock code: 1833)) since May 2018, (iii) an independent non-executive director of Beijing North Star Company Limited (a company listed on the Stock Exchange (stock code: 588) and the Shanghai Stock Exchange (stock code: 601588)) since May 2021, and (iv) an independent non-executive director of OneConnect Financial Technology Co., Ltd (a company listed on the Stock Exchange (stock code: 6638) and the New York Stock Exchange (ticker: OCFT)) since October 2020.

Dr. Chow was a Member of The National Committee of the Chinese People's Political Consultative Conference, for four sessions covering 20 years from 2003 to 2023. Dr. Chow served as the President of The Law Society of Hong Kong from 1997 to 2000, Chairman of the Process Review Panel for the SFC from 2006 to 2012, Chairman of Process Review Panel for the Financial Reporting Council from 2015 to 2020, and Chairman of The Hong Kong Jockey Club from 2018 to 2020.

Dr. Chow was awarded the Justice of the Peace in 1998 and the Silver Bauhinia Star in 2003 by the Government of Hong Kong Special Administrative Region. He was admitted to the Honorary Fellowship of the Hong Kong Institute of Education in March 2010, the Honorary Fellowship of King's College London in July 2013, and the Roll of Honour of The Law Society of Hong Kong in 2015.

Dr. Chow was awarded a doctoral degree in social sciences honoris causa from Hong Kong Metropolitan University (formerly known as the Open University of Hong Kong) in Hong Kong in December 2018 and a doctoral degree of law honoris causa from the Hong Kong University of Science and Technology in Hong Kong in November 2021.

Mr. LI Yinquan was appointed as our independent non-executive Director.

Mr. Li served respectively as (i) the general manager of financial department, chief financial officer and vice president of China Merchants Group Limited, (ii) a chief executive officer of China Merchants Capital Investment Co., Ltd., (iii) a director of China Merchants Port Holdings Company Limited (formerly known as China Merchants Holdings (International) Company Limited ) (a company listed on the Stock Exchange (stock code: 144)), (iv) a director of China Merchants Bank Co., Ltd. (a company listed on the Stock Exchange (stock code: 3968) and the Shanghai Stock Exchange (stock code: 600036)), and (v) a director of China Merchants China Direct Investments Limited (a company listed on the Stock Exchange (stock code: 133)) from March 2000 to December 2017. Concurrently, Mr. Li also served as directors of a number of other listed companies, including an independent non-executive director of Sound Group Inc. (a company listed on NASDAQ (ticker: SOGP) (formerly known as Lizhi Inc.) from January 2020 to June 2021, an independent non-executive director of Kimou Environmental Holding Limited (a company listed on the Stock Exchange (stock code: 6805)) from June 2019 to December 2022, and an independent non-executive director of China Agri-Products Exchange Limited (a company listed on the Stock Exchange (stock code: 149)) from April 2024 to August 2024. Mr. Li has currently served as directors of a number of listed companies, including: (i) an independent non-executive director of Genertec Universal Medical Group Company Limited (formerly known as Universal Medical Financial and Technical Advisory Services Company Limited) (a company listed on the Stock Exchange (stock code: 2666)) since June 2015, (ii) an independent non-executive director of Million Cities Holdings Limited (a company listed on the Stock Exchange (stock code: 2892)) since June 2018, (iii) an independent non-executive director of Hong Kong Shanghai Alliance Holdings Limited (a company listed on the Stock Exchange (stock code: 1001)) since July 2018, (iv) an independent non-executive director of China Everbright Bank Company Limited (a company listed on the Stock Exchange (stock code: 6818) and the Shanghai Stock Exchange (stock code: 601818)) since June 2020, and (v) an independent non-executive director of Mainland Headwear Holdings Limited (a company listed on the Stock Exchange (stock code: 1100)) since September 2023.

Throughout the significant years of directorship in certain Hong Kong listed companies, Mr. Li has gained relevant experience in, including but not limited to, (i) the review and preparation of comparable and/or audited financial statements of Hong Kong listed companies; (ii) the review of internal control systems; and (iii) the analysis of financial statements and information of Hong Kong listed companies. Moreover, Mr. Li has also obtained vast experience in collaborating and dealing with internal and external auditors regarding the supervision of internal financial controls and the auditing of financial statements.

Mr. Li obtained his master's degree in economics from Research Institute of Finance of the People's Bank of China in Beijing, the PRC in December 1985. He obtained another master's degree in banking and finance for development from Finafrica Institute in Milan, Italy in October 1988. Mr. Li was qualified as a senior economist in the PRC in August 1989.

Dr. YAO Yang was appointed as our independent non-executive Director in October 2024.

Dr. Yao currently serves as a Boya Distinguished Professor of Peking University, a professor of economics and doctoral supervisor of the National School of Development of Peking University, the director of China Center for Economic Research, the executive director of Institute of South-South Cooperation and Development, the editor in chief of China Economic Quarterly the president of China Annual Economic Meetings, and the president of the National Economics Foundation.

Dr. Yao has served as deputy dean of the National School of Development of Peking University since October 2008, and the dean of the National School of Development of Peking University from November 2012 to January 2024. He has served as the director of China Center for Economic Research of Peking University since 2010.

Dr. Yao is a member of the Chinese Economists 50 Forum and has been awarded the 2008 and 2014 Sun Yefang Award in Economic Sciences, the First Pushan Award in 2008, the Second Pushan Award in 2010, and the Second Zhang Peigang Development Economics Award in 2008. His current major research areas include new political economy and China's economic growth under open conditions.

Dr. Yao graduated from the Management Science Center of Peking University with a master's degree in economics in 1989 and graduated from the Department of Agricultural and Applied Economics at the University of Wisconsin-Madison in the United States with a doctoral degree in development economics in 1996.

Ms. CHENG Po Chuen was appointed as our independent non-executive Director in October 2024.

Ms. Cheng served as a consultant in the business consulting division of Arthur Andersen & Co from September 1994 to May 1997. She worked in the investment banking arms of DBS Asia Capital Limited, The Hongkong and Shanghai Banking Corporation Limited and Macquarie Group from May 1997 to August 2010, with her last position as a division director in Macquarie Capital Securities Limited. Ms. Cheng joined the global wealth management division of UBS AG as head of corporate advisory group in Hong Kong in September 2010, and subsequently had served there until January 2020 with her last position as a managing director. Ms. Cheng served as the chief financial officer since January 2020 and an executive director since April 2020 in Crazy Sports Group Limited (formerly known as V1 Group Limited) (acompany listed on the Stock Exchange (stock code: 82)) until November 2023. Ms. Cheng has served as the director of development of The Hong Kong Philharmonic Society Limited since August 2024.

Ms. Cheng is a member of American Institute of Certified Public Accountants. She holds a bachelor degree in business administration from The University of Hong Kong in Hong Kong.